Cantel Medical LLC, a prominent player in the medical device industry, is headquartered in the United States. Founded in 1963, the company has established itself as a leader in infection prevention and control solutions, serving healthcare facilities across North America and beyond. Specialising in water purification, endoscope reprocessing, and dental equipment, Cantel Medical offers innovative products that enhance patient safety and operational efficiency. Their commitment to quality and compliance has earned them a strong market position, recognised for their advanced technologies and comprehensive service offerings. With a focus on improving healthcare outcomes, Cantel Medical continues to achieve significant milestones, solidifying its reputation as a trusted partner in the medical community.
How does Cantel Medical LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Cantel Medical LLC's score of 60 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Cantel Medical LLC, headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. However, the company is part of a corporate family relationship with STERIS plc, from which it inherits emissions data and climate commitments. As a merged entity, Cantel Medical LLC aligns its climate initiatives with those of STERIS plc, which has established science-based targets for emissions reduction. While specific reduction targets for Cantel Medical LLC are not detailed, the overarching commitments from STERIS plc suggest a proactive approach to addressing climate change. The absence of direct emissions data highlights the importance of corporate transparency in environmental impact reporting. As Cantel Medical LLC continues to integrate its operations with STERIS plc, it is expected to adopt and implement robust climate strategies that contribute to overall emissions reductions within the healthcare sector.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 67,071,000 | 00,000,000 | 00,000,000 | 
| Scope 2 | 75,246,000 | 00,000,000 | 000,000,000 | 
| Scope 3 | - | 000,000,000 | 000,000,000 | 
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Cantel Medical LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.